[EN] SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION [FR] DERIVES ARYLTHIO-UREE SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE LA REPLICATION VIRALE
[EN] SPINOSYN DERIVATIVES AS INSECTICIDES<br/>[FR] DÉRIVÉS DE SPINOSYNES UTILISABLES EN TANT QU'INSECTICIDES
申请人:AGRIMETIS LLC
公开号:WO2017040882A1
公开(公告)日:2017-03-09
Compositions including derivatives of spinosyns and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include spinosyn derivatives functionalized on the C5-C6 double bond of spinosyn A to provide an additional ring system. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and/or nematodes and are useful in the agricultural and animal health markets.
Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas
作者:C. R. Rasmussen、F. J. Villani, Jr.、L. E. Weaner、B. E. Reynolds、A. R. Hood、L. R. Hecker、S. O. Nortey、A. Hanslin、M. J. Costanzo、E. T. Powell、A. J. Molinari
DOI:10.1055/s-1988-27605
日期:——
An improved procedure for the preparation of arylthioureas consists of the reaction of benzoyl isothiocyanate with anilines in acetone and debenzoylation of the resultant N-aryl-N′-benzoylthioureas with 5% aqueous sodium hydroxide. Bicycloalkylthioureas and N-(arylalkyl)thioureas (e.g., 9H-9-fluorenylthiourea) are directly prepared from the corresponding isothiocyanates and ammonia.
Substituted arylthiourea derivatives useful as inhibitors of viral replication
申请人:Phadke Avinash
公开号:US20050032849A1
公开(公告)日:2005-02-10
Substituted arylthiourea compounds of Formula I,
and the pharmaceutically acceptable salts of such compounds, useful as antiviral agents, are provided herein. Certain substituted arylthioureas disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions containing one or more substituted arylthiourea compounds and one or more pharmaceutically acceptable carriers, excipients, or diluents are provided herein. Such pharmaceutical compositions may contain a substituted arylthiourea as the only active agent or may contain a combination of a substituted arylthiourea derivative and one or more other pharmaceutically active agents. Methods of treating Hepatitis C viral infections in mammals are also provided herein.
Compositions including derivatives of spinosyns and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include spinosyn derivatives functionalized on the C5-C6 double bond of spinosyn A to provide an additional ring system. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and/or nematodes and are useful in the agricultural and animal health markets.
本研究提供了包括旋光花苷衍生物的组合物以及生产旋光花苷衍生物的方法。本文所述的旋光花苷衍生物包括在旋光花苷 A 的 C5-C6 双键上官能化以提供额外环系的旋光花苷衍生物。该方法生产出的尖孢菌苷衍生物对昆虫、蛛形纲动物和/或线虫具有活性,可用于农业和动物保健市场。
Design, synthesis, and anti-HCV activity of thiourea compounds
A series of thiourea derivatives were synthesized and their antiviral activity was evaluated in a cell-based HCV subgenomic replicon assay. SAR studies revealed that the chain length and the position of the alkyl linker largely influenced the in vitro anti-HCV activity of this class of potent antiviral agents. Among this series of compounds synthesized, the thiourea derivative with a six-carbon alkyl linker at the meta-position of the central phenyl ring (10) was identified as the most potent anti-HCV inhibitor (EC50 = 0.047 mu M) with a selectivity index of 596. (C) 2009 Elsevier Ltd. All rights reserved.